Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | UCART22 |
Trade Name | |
Synonyms | UCART-22|UCART 22 |
Drug Descriptions |
UCART22 is a preparation of allogeneic T-cells expressing a chimeric antigen receptor (CAR) that targets CD22, potentially resulting in decreased tumor growth (Cancer Res July 1 2017 (77) (13 Supplement) 3763). |
DrugClasses | CD22 Immune Cell Therapy 15 |
CAS Registry Number | NA |
NCIT ID | C165696 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Alemtuzumab + Cyclophosphamide + Fludarabine + UCART22 | Alemtuzumab Cyclophosphamide Fludarabine UCART22 | 0 | 0 |
Cyclophosphamide + Fludarabine + UCART22 | Cyclophosphamide Fludarabine UCART22 | 0 | 0 |
UCART22 | UCART22 | 0 | 1 |